Cargando…

Cardiac toxicity of trastuzumab in elderly patients with breast cancer

Breast cancer (BC) is diagnosed in ≥ 65 year old women in about half of cases. Experts currently recommend that systemic therapy is offered to elderly patients with BC, if, based on their overall conditions and life expectancy, it can be reasonably anticipated that the benefits will outweigh the ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Denegri, Andrea, Moccetti, Tiziano, Moccetti, Marco, Spallarossa, Paolo, Brunelli, Claudio, Ameri, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921548/ https://www.ncbi.nlm.nih.gov/pubmed/27403145 http://dx.doi.org/10.11909/j.issn.1671-5411.2016.04.003

Ejemplares similares

A patient-centered multidisciplinary cardiac rehabilitation program improves glycemic control and functional outcome in coronary artery disease after percutaneous and surgical revascularization
por: Denegri, Andrea, et al.
Publicado: (2022)

Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation
por: Vassalli, Giuseppe, et al.
Publicado: (2012)

Association between obesity and trastuzumab-related cardiac toxicity in elderly patients with breast cancer
por: Wang, Hai-Yan, et al.
Publicado: (2017)

Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes
por: Biasco, Luigi, et al.
Publicado: (2018)

Remodeling the Human Adult Stem Cell Niche for Regenerative Medicine Applications
por: Bardelli, Silvana, et al.
Publicado: (2017)

Stem and Progenitor Cells in Human Cardiopulmonary Development and Regeneration
por: Bardelli, Silvana, et al.
Publicado: (2017)

Exosomes for Intramyocardial Intercellular Communication
por: Cervio, Elisabetta, et al.
Publicado: (2015)

Challenges in activation of remote monitoring in patients with cardiac rhythm devices during the coronavirus (COVID-19) pandemic
por: Auricchio, Angelo, et al.
Publicado: (2021)

Early cardiac unloading with ImpellaCP™ in acute myocardial infarction with ventricular septal defect
por: Via, Gabriele, et al.
Publicado: (2020)

Ultrastructural Evidence of Exosome Secretion by Progenitor Cells in Adult Mouse Myocardium and Adult Human Cardiospheres
por: Barile, Lucio, et al.
Publicado: (2012)

Human Cardiospheres as a Source of Multipotent Stem and Progenitor Cells
por: Barile, Lucio, et al.
Publicado: (2013)

“Where is the Heart?” When Cardiac Magnetic Resonance Imaging Helps if Echocardiography is Inconclusive
por: Caretta, Alessandro, et al.
Publicado: (2019)

How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy
por: Spallarossa, Paolo, et al.
Publicado: (2020)

Testosterone Antagonizes Doxorubicin‐Induced Senescence of Cardiomyocytes
por: Altieri, Paola, et al.
Publicado: (2016)

Gender-specific differences in return-to-spontaneous circulation and outcome after out-of-hospital cardiac arrest: Results of sixteen-year-state-wide initiatives
por: Auricchio, Angelo, et al.
Publicado: (2020)

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
por: Masini, Marta, et al.
Publicado: (2023)

A practical approach for the validation of sterility, endotoxin and potency testing of bone marrow mononucleated cells used in cardiac regeneration in compliance with good manufacturing practice
por: Soncin, Sabrina, et al.
Publicado: (2009)

Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population
por: Grela-Wojewoda, Aleksandra, et al.
Publicado: (2022)

Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes
por: Fabbi, Patrizia, et al.
Publicado: (2015)

Better management of out-of-hospital cardiac arrest increases survival rate and improves neurological outcome in the Swiss Canton Ticino
por: Mauri, Romano, et al.
Publicado: (2016)

Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab
por: Cao, Lu, et al.
Publicado: (2015)

Inhibition of Doxorubicin-Induced Senescence by PPARδ Activation Agonists in Cardiac Muscle Cells: Cooperation between PPARδ and Bcl6
por: Altieri, Paola, et al.
Publicado: (2012)

Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer
por: Tini, Giacomo, et al.
Publicado: (2021)

Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
por: Mercurio, Valentina, et al.
Publicado: (2020)

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study
por: Bengala, C, et al.
Publicado: (2006)

Quantification of aortic valve regurgitation by phase-contrast magnetic resonance in patients with bicuspid aortic valve: where to measure the flow?
por: Muzzarelli, Stefano, et al.
Publicado: (2013)

Chest pain and plaque rupture without high-sensitive troponin elevation
por: Moccetti, Federico, et al.
Publicado: (2019)

Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer
por: Mazzotta, Marco, et al.
Publicado: (2019)

Trastuzumab in the management of early and advanced stage breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2007)

Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
por: Marinko, Tanja, et al.
Publicado: (2014)

Breast cancer therapy and cardiovascular risk: focus on trastuzumab
por: Sandoo, Aamer, et al.
Publicado: (2015)

An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline
por: Sarocchi, Matteo, et al.
Publicado: (2018)

Anti-HER-2 therapy following severe trastuzumab-induced cardiac toxicity
por: Sadek, Ibrahim, et al.
Publicado: (2017)

Trastuzumab deruxtecan for breast cancer
Publicado: (2022)

Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study
por: Geuna, Elena, et al.
Publicado: (2020)

Cardiac side effects of trastuzumab in breast cancer patients – single centere experiences
por: Huszno, Joanna, et al.
Publicado: (2013)

Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars
por: Uifălean, Alina, et al.
Publicado: (2018)

Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy
por: Méndez-Valdés, Gabriel, et al.
Publicado: (2023)

Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function
por: Radrizzani, Marina, et al.
Publicado: (2014)

Systemic toxicities of trastuzumab‐emtansine predict tumor response in HER2+ metastatic breast cancer
por: Tang, Shou‐Ching, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iu1ipfltgkri78laust4qujup2